Vyome Holdings, Inc. (NASDAQ:HIND) is a company that is currently facing challenges in efficiently utilizing its capital. The company's Return on Invested Capital (ROIC) is a staggering -369.22%, which is far below its Weighted Average Cost of Capital (WACC) of 4.09%. This indicates that Vyome is not generating returns on its invested capital, highlighting inefficiency in capital utilization.

When comparing Vyome to its peers, Digital Brands Group, Inc. (NASDAQ:DBGI) stands out with a ROIC of -63.30% and a WACC of 38.56%. Despite its negative ROIC, DBGI has the highest ROIC to WACC ratio of -1.64 among the peers, suggesting it is the least inefficient in terms of capital utilization. This means DBGI is relatively closer to breaking even compared to others.

Palisade Bio, Inc. (NASDAQ:PALI) and Ensysce Biosciences, Inc. (NASDAQ:ENSC) also show significant inefficiencies. PALI has a ROIC of -309.15% and a WACC of 11.10%, resulting in a ROIC to WACC ratio of -27.85. ENSC, on the other hand, has a ROIC of -874.14% and a WACC of 39.34%, with a ROIC to WACC ratio of -22.22. Both companies are struggling to generate returns on their investments.

Grom Social Enterprises, Inc. (NASDAQ:GROM) and NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO) also face challenges. GROM has a ROIC of -59.49% and a WACC of 33.38%, leading to a ROIC to WACC ratio of -1.78. NRBO has a ROIC of -269.72% and a WACC of 5.00%, with a ROIC to WACC ratio of -53.94. These figures indicate that all companies in this analysis are struggling with negative ROICs, which are significantly below their respective WACCs.